FTXH
First Trust Nasdaq Pharmaceuticals ETF
stockNASDAQETF
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select pharmaceuticals stocks from the base index based on a ranking methodology of three price factors which aims to select companies that exhibit: strong growth through high average 3-, 6-, 9- and 12-month price return; value; and low expected volatility based on historical stock price fluctuation. It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 41.86 | 2026-09-28 | -2.68% | 0.174 |
| 1M | 41.77 | 2026-09-04 | -2.49% | 0.544 |
| 3M | 38.91 | 2026-07-06 | +4.68% | 0.218 |
| 6M | 34.00 | 2026-04-06 | +19.83% | 0.242 |
| 1Y | 29.69 | 2025-10-03 | +37.20% | 0.417 |
| 2Y | 28.57 | 2024-10-04 | +42.58% | — |
| 5Y | 25.47 | 2021-10-04 | +59.95% | 0.480 |
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) stock price today is $40.74, and today's volume is 53,734. FTXH is down 0.208% today. The 30 day average volume is 219,254. FTXH market cap is $1.05B with 25.75M shares outstanding.